RxDoctor Payments DataLook up a doctor →

Wayne Kotzker, MD

Nephrology · Fort Lauderdale, FLNPI 1124120019

Payments from drug & device makers

$3,381,587in general payments, 2019–2025

Across 1,545 payments — averaging $2188.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1.5M
  • Bayer$806K
  • GSK$459K
  • Pfizer$318K
  • Amgen$85K
  • Travere Therapeutics, Inc.$82K
  • plus $176K from 29 others
$912in research payments, 2019–2025

Across 9 payments — averaging $101.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$912

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,381,587 in reported general payments places this provider in the 95th percentile of 756 nephrology providers in Florida.

See all nephrology providers in Florida

Medicare billing

Part B allowed, 2024
$452,189
Medicare patients
888
Services billed
4,935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Fort Lauderdale

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →